Treatment of type 2 diabetes with the designer cytokine IC7Fc
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Raw data for Findeisen, Allen et al. Treatment of type 2 diabetes with the designer cytokine IC7Fc
应用场景：
创建时间：
2019-08-16
相关数据集
Available IPD datapackage for study 'A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy'
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with metformin and sul
Mendeley Data2024-06-07 更新120
Dataset from A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other OAD
This trial is conducted in Asia. The aim of this trial is to confirm the superiority of insulin degludec/liraglutide versus insulin degludec in controlling glycaemia in Chinese subjects with type 2 di
NIAID Data Ecosystem00
The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults
Dataset used for the study titled "A relative cost of control analyses of once weekly semaglutide versus dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults"
Zenodo2023-04-24 更新00
Utility value data.
Background Degludec insulin liraglutide injection is the world’s first and only approved basal insulin GLP-1RA injection in China (GLP-1RA stands for Glucagon-Like Peptide-1 Receptor Agonist. This stu
NIAID Data Ecosystem10
DataSheet1_Accessible Type 2 diabetes medication through stable expression of Exendin-4 in Saccharomyces cerevisiae.ZIP
Diabetes mellitus affects roughly one in ten people globally and is the world’s ninth leading cause of death. However, a significant portion of chronic complications that contribute to mortality can b
NIAID Data Ecosystem00
